It is important to note that while the focus on blocking SARS-CoV-2 entry into vulnerable cells is via ACE2, a new discovery highlights that neuropilin-1 (NRP1), a receptor involved in multiple physiological processes and expressed on many cell types (Roy et al., 2017), is being utilized by the virus to facilitate entry and infection (Cantuti-Castelvetri et al., 2020; Daly et al., 2020). The gene discussed is NRP1; the disease is infection.